PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

BMC Cancer

Topics

Medicine

Internal Medicine

Surgery

Otorhinolaryngology

Randomized Controlled Trial

Show all topics

DOI

10.1186/s12885-015-1598-x

License

CC-BY

Other Formats

PDF